1. Home
  2. POWL vs MDGL Comparison

POWL vs MDGL Comparison

Compare POWL & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Powell Industries Inc.

POWL

Powell Industries Inc.

HOLD

Current Price

$294.11

Market Cap

9.9B

Sector

Energy

ML Signal

HOLD

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

HOLD

Current Price

$478.89

Market Cap

11.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POWL
MDGL
Founded
1947
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.9B
11.1B
IPO Year
1995
2005

Fundamental Metrics

Financial Performance
Metric
POWL
MDGL
Price
$294.11
$478.89
Analyst Decision
Buy
Strong Buy
Analyst Count
4
12
Target Price
$184.25
$674.45
AVG Volume (30 Days)
524.9K
249.1K
Earning Date
05-04-2026
05-06-2026
Dividend Yield
0.14%
N/A
EPS Growth
20.91
41.32
EPS
2.39
N/A
Revenue
$448,716,000.00
$180,133,000.00
Revenue This Year
$11.20
$58.39
Revenue Next Year
$9.12
$48.55
P/E Ratio
$121.53
N/A
Revenue Growth
13.34
N/A
52 Week Low
$174.55
$275.00
52 Week High
$612.50
$615.00

Technical Indicators

Market Signals
Indicator
POWL
MDGL
Relative Strength Index (RSI) 51.77 43.54
Support Level $283.89 $456.39
Resistance Level $318.28 $502.97
Average True Range (ATR) 20.60 19.44
MACD 1.47 -2.32
Stochastic Oscillator 73.38 38.24

Price Performance

Historical Comparison
POWL
MDGL

About POWL Powell Industries Inc.

Powell Industries Inc is a United States-based company that develops, designs, manufactures, and services custom-engineered equipment and systems for electrical energy distribution, control, and monitoring. The company's principal products comprise integrated power control room substations, custom-engineered modules, electrical houses, traditional and arc-resistant distribution switchgear and control gear, and so on. These products are applied in oil and gas refining, offshore oil and gas production, petrochemical, pipeline, terminal, mining and metals, light-rail traction power, electric utility, pulp and paper, and other heavy industrial markets. The company generates the majority of its sales from the United States, and the rest from Canada, Europe, Asia Pacific, and other regions.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.

Share on Social Networks: